Six years since COVID-19 was declared a pandemic, here’s a snapshot of preparedness at a time of global health funding cuts, policy shifts and the spread of misinformation.
In 2020, as scientists around the world were racing to understand COVID-19, Prof. Roy Bar-Ziv and his team at the Weizmann Institute of Science started developing a DNA chip that could not only ...
Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration’s (FDA) recent clearance of Roche’s blood-based Alzheimer’s disease test will boost ...
Add Yahoo as a preferred source to see more of our stories on Google. Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. ...
Morning Overview on MSN
DeepRare AI beats doctors in rare disease diagnosis test
A new artificial intelligence system called DeepRare has beaten experienced rare-disease physicians at their own specialty, ...
The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results